ERGO is part of the EURION Cluster Group of eight research projects from the Call ‘New Testing and Screening Methods to Identify Endocrine Disrupting Chemicals’. Funded by the EU Horizon 2020 Research and Innovation Programme, this is the largest public funding of this type of research in Europe. The Cluster Group will optimise synergies and avoid overlaps between the projects.
Each project is focussing on a different aspect of new testing and screening methods identifying EDCs. However, the projects will share expertise to maximize EURION’s impact.
Assays for the identification of Thyroid Hormone axis-disrupting chemicals: Elaborating Novel Assessment strategies
Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways
Novel Testing Strategies for Endocrine Disruptors in the Context of Developmental NeuroToxicity
Breaking down the wall between human health and environmental testing of endocrine disrupting chemicals: EndocRine Guideline Optimisation
Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach
Generation Of Novel, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds
An integrative strategy of testing systems for identification of Endocrine Disrupters related to metabolic disorders
A multistage model of thyroid gland function for screening endocrine disrupting chemicals in a biologically sex-specific manner